Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia

被引:85
作者
Mulenga, Lloyd B. [1 ]
Kruse, Gina [1 ]
Lakhi, Shabir [2 ]
Cantrell, Ronald A. [1 ,3 ,4 ]
Reid, Stewart E. [1 ,3 ,4 ]
Zulu, Isaac [5 ,6 ]
Stringer, Elizabeth M. [1 ,3 ,4 ]
Krishnasami, Zipporah [3 ,4 ]
Mwinga, Alwyn [5 ]
Saag, Michael S. [3 ,4 ]
Stringer, Jeffrey S. A. [1 ,3 ,4 ]
Chi, Benjamin H. [1 ,3 ,4 ]
机构
[1] Ctr Infect Dis Res, Lusaka, Zambia
[2] Univ Teaching Hosp, Lusaka, Zambia
[3] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[4] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA
[5] US Ctr Dis Control & Prevent Global AIDS Program, Lusaka, Zambia
[6] Univ Zambia, Sch Med, Lusaka, Zambia
基金
美国国家卫生研究院;
关键词
antiretroviral therapy; HIV; mortality; renal disease; sub-Saharan Africa; survival; Zambia;
D O I
10.1097/QAD.0b013e328307a051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine the association between baseline renal insufficiency and mortality among adults initiating antiretroviral therapy (ART) in an urban African setting. Design: Open cohort evaluation. Methods: We examined mortality according to baseline renal function among adults initiating ART in Lusaka, Zambia. Renal function was assessed by the Cockcroft-Gault method, the Modification of Diet in Renal Disease equation, and serum creatinine. Results: From April 2004 to September 2007, 25 779 individuals started ART with an available creatinine measurement at baseline. When creatinine clearance was calculated by the Cockcroft-Gault method, 8456 (33.5%) had renal insufficiency: 73.5% were mild (60-89 ml/min), 23.4% moderate (30-59 ml/min), and 3.1% severe (<30 ml/min). Risk for mortality at or before 90 days was elevated for those with mildly [adjusted hazard ratio (AHR) 1.7; 95% confidence interval (951% CI) = 1.5-1.9], moderately (AHR = 2.3; 95% CI 2.0-2.7), an
引用
收藏
页码:1821 / 1827
页数:7
相关论文
共 39 条
[1]  
ANDIA I, 2005, 3 IAS C HIV PATH TRE
[2]  
[Anonymous], 2006, REP GLOB AIDS EP
[3]   Herbs and the kidney [J].
Bagnis, CI ;
Deray, G ;
Baumelou, A ;
Le Quintrec, M ;
Vanherweghem, JL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (01) :1-11
[4]   Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia [J].
Bolton-Moore, Carolyn ;
Mubiana-Mbewe, Mwangelwa ;
Cantrell, Ronald A. ;
Chintu, Namwinga ;
Stringer, Elizabeth M. ;
Chi, Benjamin H. ;
Sinkala, Moses ;
Kankasa, Chipepo ;
Wilson, Craig M. ;
Wilfert, Catherine M. ;
Mwango, Albert ;
Levy, Jens ;
Abrams, Elaine J. ;
Bulterys, Marc ;
Stringer, Jeffrey S. A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (16) :1888-1899
[5]  
Burns GC, 1997, J AM SOC NEPHROL, V8, P1140
[6]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[7]   Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment [J].
Couchoud, C ;
Pozet, N ;
Labeeuw, M ;
Pouteil-Noble, C .
KIDNEY INTERNATIONAL, 1999, 55 (05) :1878-1884
[8]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[9]   Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa [J].
Erikstrup, Christian ;
Kallestrup, Per ;
Zinyama, Rutendo ;
Gomo, Exnevia ;
Mudenge, Boniface ;
Gerstoft, Jan ;
Ullum, Henrik .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (04) :478-483
[10]   Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids [J].
Eustace, JA ;
Nuermberger, E ;
Choi, M ;
Scheel, PJ ;
Moore, R ;
Briggs, WA .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1253-1260